此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound (AKE-MECC)

2016年6月29日 更新者:University Hospital Inselspital, Berne

Aortic Valve Replacement Using Closed Extracorporeal Circuit. Minimized Versus Conventional Extracorporeal Circulation Technique: Qualitative Differences

In this study, the investigators aim to compare cerebral embolic load in patients undergoing surgical aortic valve replacement using either the minimized extracorporeal circulation or the conventional extracorporeal circulation technique. The detection of cerebral emboli is performed not-invasively by transcranial Doppler detection of high-intensity transient signals representing solid or gaseous microembolism in the middle cerebral arteries. The investigators hope to get more insight in the mechanism (incl. quantity) of cerebral embolism during aortic valve surgery using extracorporeal circulation.

研究概览

详细说明

Background

The gold standard to treat severe aortic valve stenosis is currently the surgical aortic valve replacement (SAVR) using conventional extracorporeal circulation (CECC). SAVR, however, can be performed also on minimized extracorporeal circulation (MECC), which is characterized by reduced priming volume and interfaces between blood and artificial surfaces and blood-air interface, respectively. Further technical developments of the MECC system together with reports on less induction of the coagulation cascade and activation of inflammatory systemic response may account for a reduced incidence of microbubble generation with MECC system.

Objective

The aim of the is to investigate the procedural-related incidence of high-intensity transient signals (HITS) representing solid or gaseous microembolism reaching the cerebral vessels.

Methods

Patients undergoing SAVR are included in the study and randomised to either MECC or CECC technique. HITS are continuously bilaterally detected during the entire intraoperative period by transcranial Doppler ultrasound.

研究类型

介入性

注册 (实际的)

48

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Bern、瑞士、3010
        • University Hospital Bern

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Isolated Severe Aortic Valve Stenosis
  • No other cardiac disease
  • No other coronary heart disease
  • Written informed consent

Exclusion Criteria

  • Double valve surgery
  • Concomitant coronary artery bypass surgery
  • Vascular surgery
  • Age < 18 yrs.
  • Age > 80 yrs.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Conventional Extracorporeal Circulation Technique
This group of patients receives surgical aortic valve replacement using CECC.
实验性的:Minimized Extracorporeal Circulation Technique
This group of patients receives surgical aortic valve replacement using MECC.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Total and interval-related cerebral microembolic load as measured by transcranial Doppler
大体时间:Intraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)
Intraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)

次要结果测量

结果测量
大体时间
Cerebral complications, e.g. delirium and stroke as detected clinically
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
Redo surgery
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
ICU length of stay
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
Extubation time
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
Thromboembolic complications
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital infections
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital Mortality
大体时间:In-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital period (until hospital discharge, duration approx. 7-10 days)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Thierry Carrel, MD, PhD、Department of Cardiovascular Surgery

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年6月1日

初级完成 (实际的)

2016年3月1日

研究完成 (实际的)

2016年6月1日

研究注册日期

首次提交

2014年12月2日

首先提交符合 QC 标准的

2014年12月2日

首次发布 (估计)

2014年12月4日

研究记录更新

最后更新发布 (估计)

2016年6月30日

上次提交的符合 QC 标准的更新

2016年6月29日

最后验证

2016年6月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅